Trial · NCT01646385
Adverse events48
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 48
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Pneumonia | Infections and infestations | Etanercept | 205 | 3,529 | |
| serious | Pneumonia | Infections and infestations | nbDMARDs | 225 | 2,864 | |
| serious | Septicaemia | Infections and infestations | Etanercept | 34 | 3,529 | |
| serious | Septicaemia | Infections and infestations | nbDMARDs | 28 | 2,864 | |
| serious | Bone/Joint infection | Infections and infestations | Etanercept | 83 | 3,529 | |
| serious | Bone/Joint infection | Infections and infestations | nbDMARDs | 31 | 2,864 | |
| serious | Other serious infection | Infections and infestations | Etanercept | 314 | 3,529 | |
| serious | Other serious infection | Infections and infestations | nbDMARDs | 171 | 2,864 | |
| serious | Lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Etanercept | 11 | 3,529 | |
| serious | Lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | nbDMARDs | 18 | 2,864 | |
| serious | Myeloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Etanercept | 1 | 3,529 | |
| serious | Myeloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | nbDMARDs | 4 | 2,864 | |
| serious | Leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Etanercept | 6 | 3,529 | |
| serious | Leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | nbDMARDs | 7 | 2,864 | |
| serious | Non-melanoma skin cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Etanercept | 79 | 3,529 | |
| serious | Non-melanoma skin cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | nbDMARDs | 79 | 2,864 | |
| serious | Solid tumours | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Etanercept | 153 | 3,529 | |
| serious | Solid tumours | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | nbDMARDs | 158 | 2,864 | |
| serious | Congestive heart failure | Cardiac disorders | Etanercept | 28 | 3,529 | |
| serious | Congestive heart failure | Cardiac disorders | nbDMARDs | 36 | 2,864 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01646385/events